By Kelly Oliveira & Ismar Costa e Silva, Brazil Our daughter, Rafaella, had always been a healthy girl. She loved to skate, swim, play ball, and dance. She was learning to play guitar when her Gardasil nightmare began. Rafaella Barbosa de Oliveira lives in Resende, RJ, Brazil. She was thirteen years old when she got […]
Japan stands by withdrawal of HPV vaccines from national schedule
[SaneVax: Over a year ago, Japan withdrew HPV vaccines from their national immunization schedule in response to concerns over serious adverse reactions reported by many recipients of Gardasil and Cervarix. Investigations to date have not causally linked the symptoms reported directly to either vaccine. Nevertheless, Japan’s Ministry of Health has chosen to apply the precautionary principle […]
How to determine value of a vaccine
By Sandy Lunoe, Guest Author International health authorities use enormous resources to promote every new vaccine developed as providing nothing but benefits for the average medical consumer and society as a whole. Efforts are focused on increasing uptake of various vaccines. However, there are serious considerations which should be adequately addressed prior to the issue […]
Anti HPV antibodies Levels among vaccinated and non-vaccinated Ugandan Girls
The levels of anti-HPV16/18 and anti-HPV31/33/35/45/52/58 antibodies among AS04-adjuvanted HPV16/18 vaccinated and non-vaccinated Ugandan girls aged 10–16 years Miriam Nakalembe1*, Cecily Banura2, Proscovia B Namujju34 and Florence M Mirembe1 Abstract Background Data on Human Papilloma virus (HPV) vaccine immune response in sub-Saharan Africa is still sparse yet such knowledge is critical for optimal implementation and monitoring […]
Monitoring Impact of a National HPV Vaccination Program in Japan (MINT Study): Rationale, Design and Methods
Monitoring Impact of a National HPV Vaccination Program in Japan (MINT Study): Rationale, Design and Methods Koji Matsumoto1,*, Nobuo Yaegashi2, Takashi Iwata3, Kazuya Ariyoshi4, Kiyoshi Fujiwara5, Yuko Shiroyama6, Tomoka Usami7, Yoshiaki Kawano8, Koji Horie9, Kouichiro Kawano10, Kiichiro Noda11 and Hiroyuki Yoshikawa1 for MINT Study Group Abstract We have developed a collaborative hospital-based approach to monitoring the impact of a human papillomavirus vaccine on cervical cancer, its precursor lesions […]
- « Previous Page
- 1
- …
- 44
- 45
- 46
- 47
- 48
- …
- 448
- Next Page »
